Rocket


Overview
Financials
News + Filings

 
 

Poseida Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues30.93.09.8
            Revenue growth934.6%-69.4% 
Cost of goods sold42.022.714.6
Gross profit-11.1-19.7-4.8
            Gross margin-36.0%-658.9%-49.6%
General and administrative9.75.55.4
EBIT-42.0-19.7-4.8
            EBIT margin-136.0%-658.9%-49.6%
Pre-tax income-44.6-20.2-4.7
Income taxes0.20.50.2
Net income0.00.00.0
            Net margin0.0%0.0%0.0%
 
Diluted EPS  $0.00
Shares outstanding (diluted)  12,909.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy